Eastern Europe is responsible for 82% of 159,420 new cases of HIV infection that have been diagnosed in 2017 in Europe, according to a report of today's & # 39; a World Health Organization.
The report, carried out by the European Center for Syndication and Control (ECDC) and the WHO Regional Office for Europe, mentions that in 15 countries in & nbsp; The eastern region has 130,881 new HIV cases have been identified, with the highest rates in Russia, Ukraine, Belarus and Moldova.
On the contrary, the western region, Portugal, the European Union and European economic countries, has seen a decline in new diagnostic targets, especially by a 20% reduction since 2015 between men & 39 She has sex with men.
In Portugal, data collected by the National Institute of Health Doctor Ricardo Jorge reminded a reduction to less than half the number of new HIV diagnoses in the last decade, of 2,238 cases, a correct 21.2 per 100,000 inhabitants In 2008, to 1,068, like 10.3 per 100,000 people until 2017.
From New HIV Diagnostics in & nbsp; The portals in 2017, 768, or 72% were men, compared to only 300 women's fowl, according to the report released by WHO released days for the 30th anniversary of # 39; A World Day on December 1.
The study reports that heterosexual transmission to 57% of new diagnoses in 2017 is reported in Portugal, followed by transfers between men who have sexually abusive men, 37% of new diagnostics last year.
On the other hand, the transfer of drug use into 957 in 95 years of 370 new HIV-related drugs totaled up to 18 in 2016, a success offered to HIV prevention, testing and treatment programs for drug use users.
For Zsuzsanna Jakab, regional director WHO for Europe, "it is difficult to talk about good news in the face of another year of untapped high numbers of people who are HIV infection."
They do not believe that it may be enough to compile 90-90-90 to 2020, which is 90% of all HIV diagnostics, antiretroviral therapy for 90% of human beings and the viral oppression In 90% of people treated.
The strategy for the future, he said, must be to adapt interventions, invest in "prevention, testing and treatment, especially in major populations."